首页> 外文期刊>Growth Factors >Long-term effects for acute phase myocardial infarct VEGF165 gene transfer cardiac extracellular matrix remodeling.
【24h】

Long-term effects for acute phase myocardial infarct VEGF165 gene transfer cardiac extracellular matrix remodeling.

机译:对急性期心肌梗死VEGF165基因转移心脏细胞外基质重塑的长期影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Cardiac remodeling is ultimately regulated by components of the extracellular matrix (ECM). We investigated the important role that growth factors play in the regulation of ECM remodeling that occurs as a consequence of myocardium damage. METHODS AND RESULTS: Rats were submitted to the ligation of the left anterior coronary artery and pcDNA3-vascular endothelial growth factor (VEGF)(165) was immediately injected intramyocardially in the treated group. The animals were divided into large size myocardium infarction (LMI) and small size myocardium infarction, with or without gene transfer. The plasmid-containing DNA encoding VEGF(165) was injected into the cardiac muscle and its effect was observed on the ECM components. Glycosaminoglycans were identified and quantified by agarose gel based electrophoresis and ELISA as well as immunocytochemistry to examine specific cathepsin B, heparanase, and syndecan-4 changes. The amounts of hyaluronic acid (HA; p < 0.005), DS, chondroitin sulfate, and heparan sulfate (p < 0.001) were significantly increased in the LMI treated group in comparison to the other groups, which correlates with the decrease in the expression of heparanase. A decrease in the molecular mass of HA was found in the scar tissue of treated group. CONCLUSIONS: The data obtained strongly support the idea that changes in the ECM and its components are important determinants of cardiac remodeling after myocardium infarct and may be essential for inflammatory response and attempt to stabilize the damage and provide a compensatory mechanisms to maintain cardiac output since the ECM components analyzed are involved with angiogenesis, cell proliferation and differentiation.
机译:背景:心脏重塑最终受细胞外基质(ECM)的成分调控。我们调查了生长因子在ECM重塑调节中的重要作用,ECM重塑是心肌损伤的结果。方法与结果:大鼠结扎左前冠状动脉,并立即心肌内注射pcDNA3-血管内皮生长因子(VEGF)(165)。将动物分为有或没有基因转移的大号心肌梗塞(LMI)和小号心肌梗塞。将包含编码VEGF(165)的质粒的DNA注入心肌,并观察其对ECM成分的影响。通过基于琼脂糖凝胶的电泳和ELISA以及免疫细胞化学来鉴定和定量糖胺聚糖,以检测特定的组织蛋白酶B,乙酰肝素酶和syndecan-4的变化。与其他组相比,LMI治疗组的透明质酸(HA; p <0.005),DS,硫酸软骨素和硫酸乙酰肝素的量显着增加,这与LMI表达的降低相关乙酰肝素酶。在治疗组的瘢痕组织中发现HA的分子量降低。结论:获得的数据强烈支持以下观点:ECM及其成分的变化是心肌梗塞后心脏重塑的重要决定因素,对于炎症反应和稳定损伤的尝试并提供补偿机制以维持心输出量可能是必不可少的。分析的ECM成分与血管生成,细胞增殖和分化有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号